Se Chang Park

Prof. Se Chang Park

College of Veterinary Medicine, Seoul National University
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Research in Microbiology
Verified
Journal Article
Closed access
TNToshihiro Nakai
Toshihiro Nakai
SPSe Chang Park
Se Chang Park

1 April 2000 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
SPSe Chang Park
Se Chang Park
ISIchiro Shimamura
Ichiro Shimamura
MFMinoru Fukunaga
Minoru Fukunaga
KMKoh-Ichiro Mori
Koh-Ichiro Mori
TNToshihiro Nakai
Toshihiro Nakai
Two types of bacteriophage specific to Pseudomonas plecoglossicida , the causative agent of bacterial hemorrhagic ascites disease in cultured ayu fish ( Plecoglossus altivelis ), were isolated from diseased ayu and the rearing pond water. One type of phage, which formed small plaques, was tentatively classified as a member of the family Myoviridae , and the other type, which formed large plaques, was classified as a member of the family Podoviridae . All 27 strains of P. plecoglossicida examined, which were isolated from diseased ayu from geographically different areas in 1991 to 1999, exhibited quite similar sensitivities to either type of phage. One strain of P. plecoglossicida was highly virulent for ayu, and the 50% lethal dose (LD 50 ) when intramuscular injection was used was 10 1.2 CFU fish −1 ; in contrast, phage-resistant variants of this organism were less virulent (LD 50 , >10 4 CFU fish −1 ). Oral administration of phage-impregnated feed to ayu resulted in protection against experimental infection with P. plecoglossicida . After oral administration of P. plecoglossicida cells of this bacterium were always detected in the kidneys of control fish that did not receive the phage treatment, while the cells quickly disappeared from the phage-treated fish. Bacterial growth in freshwater was lower in the presence of phage, and the number of phage PFU increased rapidly. These results suggest that it may be possible to use phage to control the disease caused by P. plecoglossicida .

1 October 2015 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
Sib Sankar GiriSib Sankar Giri
Sib Sankar Giri
SSShib Sankar Sen
Shib Sankar Sen
CCCheng Chi
Cheng Chi
HKHyoun Joong Kim
Hyoun Joong Kim
SYSaekil Yun
Saekil Yun
VSV. Sukumaran
V. Sukumaran

1 January 2003 in Diseases of Aquatic Organisms
Verified
Journal Article
Open access
PDF file
SPSe Chang Park
Se Chang Park
TNToshihiro Nakai
Toshihiro Nakai
Two previously isolated phages were used to examine the therapeutic effects against Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis. Phage PPp-W4 (Podoviridae) inhibited the in vitro growth of P. plecoglossicida more effectively than Phage PPpW-3 (Myoviridae), and a mixture (PPpW-3/W-4) of the 2 phages exhibited the highest inhibitory activity. In phage therapy experiments, ayu were fed P. plecoglossicida-impregnated feed (10(7) CFU fish(-1)) and then fed phage-impregnated feed (10(7) PFU fish(-1)). Mortalities of fish receiving PPpW-3, PPpW-4, PPpW-3/W-4, and a control fish receiving no phages were 53.3, 40.0, 20.0 and 93.3%, respectively. Phage (PPpW-3/W-4)-receiving fish also showed high protection against water-borne infection with P. plecoglossicida. In a field trial, when phage (PPpW-3/W-4)-impregnated feed was administered to ayu in a pond where the disease occurred naturally, daily mortality of fish decreased at a constant level (5% d(-1)) to one-third after a 2 wk period. The causal relationship of phages in this phenomenon was verified by the long-lasting appearance of administered phages in the kidneys of the fish, and a disappearance of P. plecoglossicida from apparently healthy fish. Neither phage-resistant organisms nor phage-neutralizing antibodies were detected in diseased fish or apparently healthy fish, respectively. These results indicate the potential for phage control of the disease.

1 January 2009 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
HJHua Jin
Hua Jin
CXCheng-Xiong Xu
Cheng-Xiong Xu
HLHwang-Tae Lim
Hwang-Tae Lim
SPSung-Jin Park
Sung-Jin Park
JSJi-Young Shin
Ji-Young Shin
MCMyung-Haing Cho
Myung-Haing Cho
Rationale: Phosphate (Pi) is an essential nutrient to living organisms. Recent surveys indicate that the intake of Pi has increased steadily. Our previous studies have indicated that elevated Pi activates the Akt signaling pathway. An increased knowledge of the response of lung cancer tissue to high dietary Pi may provide an important link between diet and lung tumorigenesis. Objectives: The current study was performed to elucidate the potential effects of high dietary Pi on lung cancer development. Methods: Experiments were performed on 5-week-old male K-rasLA1 lung cancer model mice and 6-week-old male urethane-induced lung cancer model mice. Mice were fed a diet containing 0.5% Pi (normal Pi) and 1.0% Pi (high Pi) for 4 weeks. At the end of the experiment, all mice were killed. Lung cancer development was evaluated by diverse methods. Measurement and Main Results: A diet high in Pi increased lung tumor progression and growth compared with normal diet. High dietary Pi increased the sodium-dependent inorganic phosphate transporter-2b protein levels in the lungs. High dietary consumption of Pi stimulated pulmonary Akt activity while suppressing the protein levels of tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 as well as Akt binding partner carboxyl-terminal modulator protein, resulting in facilitated cap-dependent protein translation. In addition, high dietary Pi significantly stimulated cell proliferation in the lungs of K-rasLA1 mice. Conclusions: Our results showed that high dietary Pi promoted tumorigenesis and altered Akt signaling, thus suggesting that careful regulation of dietary Pi may be critical for lung cancer prevention as well as treatment.

19 February 2014 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JJJin Woo Jun
Jin Woo Jun
TSTae Hoon Shin
Tae Hoon Shin
JKJi Hyung Kim
Ji Hyung Kim
SSSang Phil Shin
Sang Phil Shin
JHJee Eun Han
Jee Eun Han
SPSe Chang Park
Se Chang Park
Background. Recently isolated Vibrio parahaemolyticus strains have displayed multiple antibiotic resistance. Alternatives to conventional antibiotics are needed, especially for the multiple-antibiotic–resistant V. parahaemolyticus pandemic strain. Methods. A bacteriophage, designated pVp-1, showed effective infectivity for multiple-antibiotic–resistant V. parahaemolyticus and V. vulnificus, including V. parahaemolyticus pandemic strains. The therapeutic potential of the phage was studied in a mouse model of experimental infection using a multiple-antibiotic–resistant V. parahaemolyticus pandemic strain. We monitored the survivability and histopathological changes, quantified the bacterial and phage titers during phage therapy, and observed the immune response induced by phage induction. Results. Phage-treated mice displayed protection from a V. parahaemolyticus infection and survived lethal oral and intraperitoneal bacterial challenges. Conclusions. To the best of our knowledge, this is the first report of phage therapy in a mouse model against a multiple-antibiotic–resistant V. parahaemolyticus pandemic strain infection.